3m CO

3M Company announced robust second-quarter 2026 financial results, exceeding expectations with mid-single-digit sales growth and double-digit EPS growth, leading to an increase in full-year guidance.

3M Company announced the election of Jennifer W. Rumsey, Chair and CEO of Cummins Inc., to its Board of Directors, effective June 5, 2026, and appointed her to the Science, Technology and Sustainability Committee.

3M Company shareholders elected ten directors, ratified its auditor, and approved executive compensation at the 2026 annual meeting.

3M Company has entered into a new credit agreement for a $1.43 billion term loan and a $200 million revolving credit facility to finance an acquisition.

3M announced first-quarter 2026 financial results, with GAAP sales up 1.3% to $6.0 billion and adjusted EPS rising 14% year-over-year to $2.14, while reiterating its full-year 2026 financial outlook.

3M Company announced the election of Neil G. Mitchill, Jr., Executive Vice President and CFO of RTX Corporation, to its Board of Directors, effective February 6, 2026.

3M Company announced its Q2 2026 financial results, showing increased net sales and operating income, while continuing to address significant legal and environmental liabilities.

3M Company's Q1 2026 filing reveals a dip in net income and EPS compared to the prior year, alongside significant ongoing legal and environmental provisions, particularly related to PFAS litigation.

3M reports a 3.5% increase in net sales for Q3 2025, driven by strength in safety and electronics, but GAAP EPS declined significantly due to special items including litigation charges.

3M's second quarter 2025 GAAP earnings per share declined significantly due to substantial legal settlement charges, while adjusted results showed growth, as the company continues its PFAS manufacturing exit and manages ongoing litigation.

3M's Q1 2025 earnings per share jumped 61% to $2.04, driven by productivity and lower restructuring costs, even as sales dipped slightly to $5.95 billion.

3M's Q3 2024 results show a mixed performance with a net income of $1.37 billion, influenced by the spin-off of Solventum and ongoing litigation settlements.

3M delivered slight sales growth in 2025, lifted margins on an adjusted basis, completed its PFAS manufacturing exit, and advanced major legal settlements while boosting dividends and buybacks.

3M's 2024 full-year report reflects a mixed performance amid significant litigation settlements, restructuring charges, and the spin-off of its healthcare business, Solventum.

3M's annual incentive plan and 10-K filing detail executive compensation structures, business segment performance, and strategic initiatives, including a planned healthcare spin-off and PFAS manufacturing exit.

Theresa E Reinseth, Sr Vice President & CAO of 3M Co, sold 924 shares of common stock on July 23, 2026 for $169.42 per share.

John Patrick Banovetz, Executive Vice President of 3M Co, sold 7,880 shares of common stock on July 23, 2026 for $170.44 per share.

Kevin H Rhodes, EVP, Chief Legal Off & Secret of 3M Co, sold 7,669 shares of common stock on July 22, 2026 for $171.20 per share.

Christian T Goralski Jr, Group President of 3M Co, sold 4,902 shares of common stock on July 22, 2026 for $170.46 per share.

Wendy Bauer, Group President at 3M Co., reported transactions involving common stock and restricted stock units on July 1, 2026.

Director Jennifer Rumsey of 3M Co. acquired 1,195.997 shares of common stock on June 5, 2026, as part of a deferred compensation plan.

3M Company announces strong 2025 financial results, significant innovation growth, and strategic board refreshment ahead of its May 2026 Annual Meeting.

3M Company has filed a definitive proxy statement with the SEC, outlining matters for shareholder consideration.

3M Company has filed a definitive proxy statement with the SEC, related to its upcoming shareholder meeting.

3M's 2025 proxy statement details the upcoming annual shareholder meeting, director nominees, executive compensation, and corporate governance practices following a year of significant transformation.

3M Company has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.

3M Company has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 38,598,106 shares, representing 7.4% of 3M Company's common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.8% of 3M Co.'s common stock as of March 31, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.8% of 3M Company's common stock as of March 31, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.8% of 3M Company's common stock as of March 31, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G reporting beneficial ownership of 8.8% of 3M Company common stock.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.8% of 3M Company's common stock as of March 31, 2026.